BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38012382)

  • 1. EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia.
    Patel SA; Hassan MK; Naik M; Mohapatra N; Balan P; Korrapati PS; Dixit M
    Br J Cancer; 2024 Feb; 130(2):184-200. PubMed ID: 38012382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF1A promotes miR-210/miR-424 transcription to modulate the angiogenesis in HUVECs and HDMECs via sFLT1 under hypoxic stress.
    Zhao H; Wang X; Fang B
    Mol Cell Biochem; 2022 Aug; 477(8):2107-2119. PubMed ID: 35488146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIFIA/LINC02913/IGF1R axis promotes the cell function of adipose-derived mesenchymal stem cells under hypoxia via activating the PI3K/AKT pathway.
    Xiong X; Yuan L; Yang K; Wang X
    J Transl Med; 2023 Oct; 21(1):732. PubMed ID: 37848931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop.
    Bartoszewska S; Kochan K; Piotrowski A; Kamysz W; Ochocka RJ; Collawn JF; Bartoszewski R
    FASEB J; 2015 Apr; 29(4):1467-79. PubMed ID: 25550463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
    Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
    Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
    Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
    Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EEF1A2 triggers stronger ERK mediated metastatic program in ER negative breast cancer cells than in ER positive cells.
    Hassan MK; Kumar D; Patel SA; Dixit M
    Life Sci; 2020 Dec; 262():118553. PubMed ID: 33035587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
    Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
    Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
    Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
    Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
    Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of HIF1A in endothelial adaptations to physiological and ambient oxygen.
    Jiang YZ; Li Y; Wang K; Dai CF; Huang SA; Chen DB; Zheng J
    Mol Cell Endocrinol; 2014 Jun; 391(1-2):60-7. PubMed ID: 24796659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5 activates the HIF1A/VEGF pathway by binding to TAF15 to promote wound healing in diabetic foot ulcers.
    Peng WX; He PX; Liu LJ; Zhu T; Zhong YQ; Xiang L; Peng K; Yang JJ; Xiang GD
    Lab Invest; 2021 Aug; 101(8):1071-1083. PubMed ID: 33875793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
    Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
    Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
    Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.